Definium Therapeutics, Inc. (MNMD)
NASDAQ · Healthcare
Definium Therapeutics, Inc. Cash on Hand 2020–2025
Definium Therapeutics, Inc. annual cash on hand history from 2020 to 2025. Cash on hand refers to the total amount of cash and cash equivalents held by a company.
- Definium Therapeutics, Inc. cash on hand as of December 31, 2025: 257.8M, a 5.81% decrease year-over-year.
- Definium Therapeutics, Inc. cash on hand for 2025 were 257.8M, a 5.81% decrease from 2024.
- Definium Therapeutics, Inc. cash on hand for 2024 were 273.7M, a 174.55% increase from 2023.
- Definium Therapeutics, Inc. cash on hand for 2023 were 99.7M, a 29.86% decrease from 2022.
- Definium Therapeutics, Inc. cash on hand for 2022 were 142.1M.
Cash on Hand
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Definium Therapeutics, Inc. Annual Cash on Hand (Millions of US $) | |
|---|---|
| 2025 | $258 |
| 2024 | $274 |
| 2023 | $100 |
| 2022 | $142 |
| 2021 | $134 |
| 2020 | $80 |
Definium Therapeutics, Inc. Cash on Hand — FAQ
Definium Therapeutics, Inc. (MNMD) cash on hand over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see MNMD's cash on hand history?
The chart and table above show Definium Therapeutics, Inc.'s cash on hand by year and by quarter, including the growth rate.